Inherited thrombophilias could influence the reproductive outcome in women with systemic lupus erythematosus

1Dhar P, Sokol R. Thrombophilia in systemic lupus erythematosus: A review of multiple mechanisms and resultant clinical outcomes. In: Ivanov P, Ed. Pregnancy Thrombophilia – The Unsuspected Risk. INTECH, 2013 (http://dx.doi.org/10.5772/56902).DharPSokolR. Thrombophilia in systemic lupus erythematosus: A review of multiple mechanisms and resultant clinical outcomes IvanovP Pregnancy Thrombophilia – The Unsuspected Risk. INTECH 2013 http://dx.doi.org/10.5772/56902Search in Google Scholar

2Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and metaanalysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010; 5(11): 2060-2068.SmythAOliveiraGHLahrBDBaileyKRNorbySMGarovicVD. A systematic review and metaanalysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis Clin J Am Soc Nephrol. 2010 5 11 2060 2068Search in Google Scholar

3Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010; 19(14): 1665-1673.Al ArfajASKhalilN. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia Lupus. 2010 19 14 1665 1673Search in Google Scholar

4Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369(6475): 64-67.BertinaRMKoelemanBPKosterTRosendaalFRDirvenRJde RondeH Mutation in blood coagulation factor V associated with resistance to activated protein C Nature. 1994 369 6475 64 67Search in Google Scholar

5 von Ahsen N, Lewczuk P, Schütz E, Oellerich M, Ehrenreich H. Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation. Thromb Res. 2000; 99(6): 549-556.von AhsenNLewczukPSchützEOellerichMEhrenreichH. Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation Thromb Res. 2000 99 6 549 556Search in Google Scholar

6Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation. 1998; 98(23): 2520-2526.BrattstromLWilckenDEOhrvikJBrudinL. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis Circulation. 1998 98 23 2520 2526Search in Google Scholar

7Fijnheer R, Horbach DA, Donders RC, Vilé H, von Oort E, Nieuwenhuis HK, et al. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost. 1996; 76(4): 514-517.FijnheerRHorbachDADondersRCViléHvon OortENieuwenhuisHK Factor V Leiden antiphospholipid antibodies and thrombosis in systemic lupus erythematosus Thromb Haemost. 1996 76 4 514 517Search in Google Scholar

8Regéczy N, Lakos G, Balogh I, Ajzner E, Kiss E, Szegedi G. The Leiden mutation of coagulation factor V in Hungarian SLE patients. Clin Appl Thromb Hemost. 2000; 6(1): 41-45.RegéczyNLakosGBaloghIAjznerEKissESzegediG. The Leiden mutation of coagulation factor V in Hungarian SLE patients Clin Appl Thromb Hemost. 2000 6 1 41 45Search in Google Scholar

9Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, et al. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Clin Hemorheol Microcirc. 2008; 40(2): 79-87.VayáASantaolariaMMicóLCalvoJOropesaRVillaP Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects Clin Hemorheol Microcirc. 2008 40 2 79 87Search in Google Scholar

10Kaiser R, Barton JL, Chang M, Catanese JJ, Li Y, Begovich AB, et al. Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: A meta-analysis. Genes Immun. 2009; 10(5): 495-502.KaiserRBartonJLChangMCataneseJJLiYBegovichAB Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: A meta-analysis Genes Immun. 2009 10 5 495 502Search in Google Scholar

11Kaiser R, Li Y, Chang M, Catanese J, Begovich AB, Brown EE, et al. Genetic risk factors for thrombosis in systemic lupus erythematosus. J Rheumatol. 2012; 39(8): 1603-1610.KaiserRLiYChangMCataneseJBegovichABBrownEE Genetic risk factors for thrombosis in systemic lupus erythematosus J Rheumatol. 2012 39 8 1603 1610Search in Google Scholar

12Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial throm-boembolism in patients with systemic lupus erythematosus. Blood. 2004; 104(1): 143-148.BrouwerJLBijlMVeegerNJ Kluin-NelemansHCvan der MeerJ. The contribution of inherited and acquired thrombophilic defects alone or combined with antiphospholipid antibodies to venous and arterial throm-boembolism in patients with systemic lupus erythematosus Blood. 2004 104 1 143 148Search in Google Scholar

13Hochberg MC. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9): 1725.HochbergMC. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus Arthritis Rheum 1997 40 9 1725Search in Google Scholar

14Keeling D, Mackie I, Moore GW, Greer IA, Greaves M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012; 157(1): 47-58.KeelingDMackieIMooreGWGreerIAGreavesM British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome Br J Haematol. 2012 157 1 47 58Search in Google Scholar

15Koleva R, Dimitrova V, Chernev T, Savov A, Karagjozova Zh, Mazneykova V, et al. Impact of inherited thrombophilia on the development of some pregnancy complications. Akush Ginekol (Sofia). 2005; 44(5): 18-26.KolevaRDimitrovaVChernevTSavovAKaragjozovaZhMazneykovaV Impact of inherited thrombophilia on the development of some pregnancy complications Akush Ginekol (Sofia). 2005 44 5 18 26Search in Google Scholar

16Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylene-tethraydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013; 28(8): 621-647.SimoneBDe StefanoVLeonciniEZachoJMartinelliIEmmerichJ Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden Prothrombin 20210A and Methylene-tethraydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controls Eur J Epidemiol. 2013 28 8 621 647Search in Google Scholar

17Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes? Results from a targeted evidence-based review. Genet Med. 2012; 14(1): 39-50.BradleyLAPalomakiGEBienstockJVargaEScottJA. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes? Results from a targeted evidence-based review Genet Med. 2012 14 1 39 50Search in Google Scholar

18Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod. 1999; 14(6): 1624-1627.TalJSchliamserLMLeibovitzZOhelGAttiasD. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure Hum Reprod. 1999 14 6 1624 1627Search in Google Scholar

19Reznikoff-Etiévan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 2001; 108(12): 1251-1254.Reznikoff-EtiévanMFCayolVCarbonneBRobertACouletFMilliezJ. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage BJOG 2001 108 12 1251 1254Search in Google Scholar

20Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996; 348(9032): 913-916.PrestonFERosendaalFRWalkerIDBriëtEBerntorpEConardJ Increased fetal loss in women with heritable thrombophilia Lancet. 1996 348 9032 913 916Search in Google Scholar

21Spina V, Aleandri V, Morini F. The impact of the factor V Leiden mutation on pregnancy. Hum Reprod Update. 2000; 6(3): 301-306.SpinaVAleandriVMoriniF. The impact of the factor V Leiden mutation on pregnancy Hum Reprod Update. 2000 6 3 301 306Search in Google Scholar

22Meesters EW, Hansen H, Spronk HM, Hamulyak K, Rosing J, Rowshani AT, et al. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis. 2007; 18(1): 21-28.MeestersEWHansenHSpronkHMHamulyakKRosingJRowshaniAT The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus Blood Coagul Fibrinolysis. 2007 18 1 21 28Search in Google Scholar

23Demirci FY, Dressen AS, Kammerer CM, Barmada MM, Kao AH, Ramsey-Goldman R, et al. Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus. J Rheumatol. 2011; 38(4): 652-657.DemirciFYDressenASKammererCMBarmadaMMKaoAH Ramsey-GoldmanR Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus J Rheumatol. 2011 38 4 652 657Search in Google Scholar

24Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost. 2009; 102(2): 360-370.GohilRPeckGSharmaP. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls Thromb Haemost. 2009 102 2 360 370Search in Google Scholar

25Teng Z, Wang L, Cai S, Yu P, Wang J, Gong J, et al. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: A meta-analysis based on 71 research studies. PLoS One 2013; 8(2):e55332. 10.1371/journal.pone.0055332.TengZWangLCaiSYuPWangJGongJ The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: A meta-analysis based on 71 research studies PLoS One 2013 8 2 e55332 10.1371/journal.pone.0055332Open DOISearch in Google Scholar

26Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, et al. Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors. Arthritis Rheum. 2005; 53(3): 452-459.AfeltraAVadaccaMContiLGalluzzoSMitterhoferAPFerriGM Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors Arthritis Rheum. 2005 53 3 452 459Search in Google Scholar

27Summers CM, Cucchiara AJ, Nackos E, Hammons AL, Mohr E, Whitehead AS, et al. Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus. J Rheumatol. 2008; 35(11): 2179-2186.SummersCMCucchiaraAJNackosEHammonsALMohrEWhiteheadAS Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus J Rheumatol. 2008 35 11 2179 2186Search in Google Scholar

28Wu X, Zhao L, Zhu H, He D, Tang W, Luo Y. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: A meta-analysis. Genet Test Mol Biomarkers. 2012; 16(7): 806-811.WuXZhaoLZhuHHeDTangWLuoY. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: A meta-analysis Genet Test Mol Biomarkers. 2012 16 7 806 811Search in Google Scholar

29Baumann K, Beuter-Winkler P, Hackethal A, Strowitzki T, Toth B, Bohlmann MK. Maternal factor V Leiden and prothrombin mutations do not seem to contribute to the occurrence of two or more than two consecutive miscarriages in Caucasian patients. Am J Reprod Immunol. 2013; 70(6): 518-521.BaumannK Beuter-WinklerPHackethalAStrowitzkiTTothBBohlmannMK. Maternal factor V Leiden and prothrombin mutations do not seem to contribute to the occurrence of two or more than two consecutive miscarriages in Caucasian patients Am J Reprod Immunol. 2013 70 6 518 521Search in Google Scholar

30Ozdemir O, Yenicesu GI, Silan F, Köksal B, Atik S, Ozen F, et al. Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations. Genet Test Mol Biomarkers. 2012; 16(4): 279-286.OzdemirOYenicesuGISilanFKöksalBAtikSOzenF Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations Genet Test Mol Biomarkers. 2012 16 4 279 286Search in Google Scholar